Navigation Links
Second plant pathway could improve nutrition, biofuel production

WEST LAFAYETTE, Ind. - Purdue University scientists have defined a hidden second option plants have for making an essential amino acid that could be the first step in boosting plants' nutritional value and improving biofuel production potential.

The amino acid phenylalanine is required to build proteins and is a precursor for more than 8,000 other compounds essential to plants, including lignin, which allows plants to stand upright but acts as a barrier in the production of cellulosic ethanol.

It had been believed that plants could use two pathways to create phenylalanine. Natalia Dudareva, a professor of horticulture, and Hiroshi Maeda, a postdoctoral researcher in Dudareva's laboratory, have confirmed that while plants predominantly use one pathway, they have another at their disposal. The existence of this second pathway might one day allow scientists to increase a plant's production of the essential amino acid. Their research was published in the early online version of the journal Plant Cell.

"That would allow us to increase the nutritional value of some food," Maeda said. "But also by increasing these compounds, the plants would be better able to protect themselves from changes in the environment."

Maeda added that reducing phenylalanine could lead to a reduction of lignin in plants, which would improve digestibility of cellulosic materials for ethanol production.

Phenylalanine is one of the few essential amino acids that humans and animals cannot synthesize, so it must come from plants. It is produced when sugars enter a plant's shikimate pathway, which creates a link between the processing of sugars and the generation of aromatic compounds. The next steps had not been known until now, and were thought to involve one of two proposed routes - the phenylpyruvate or arogenate pathways.

Dudareva and Maeda found a gene responsible for phenylalanine production, and suppression of the gene expression knocked out 80 percent of the phenylalanine content in petunias. The hypothesis was that the gene suppression would act like a clogged pipe, creating an abundance of compounds that would have later become phenylalanine in a normal plant.

But that's not what happened.

"These plants knew that the last step of phenylalanine production was down and slowed the first steps," Dudareva said.

Maeda said the plant created some sort of feedback mechanism that slowed down the entry point of the shikimate pathway.

Dudareva and Maeda wanted to see what would happen if they forced the shikimate pathway to function, so they gave the petunias shikimic acid. The plants were flooded with the upstream compounds as expected, but since they could not use the usual arogenate pathway to convert them to phenylalanine, they used another path that scientists had only theorized existed.

"What this tells us is this other pathway could be active under certain conditions," Dudareva said.

Understanding how the pathways work is a first step in finding ways to increase phenylalanine for boosting nutritional values of foods, or decreasing it, which may help in biofuel production.

Dudareva and Maeda will next try to determine how the plant creates feedback to the shikimate pathway. Disrupting that feedback could lead to an abundant production of phenylalanine in plants. The National Science Foundation funded the research.


Contact: Brian Wallheimer
Purdue University

Related biology news :

1. NTU and Lien Foundation launch second second wave of Environmental Endeavor
2. Measuring protein movements with nanosecond resolution
3. The AACR to host second cancer research conference in Jordan
4. A second hydrocarbon boom threatens the Peruvian Amazon
5. Pacific Biomarkers, Inc. Schedules Second Quarter Conference Call for Friday, February 12, 2010
6. Oral COTI-2 is effective in a second animal model of human pancreatic cancer
7. Secondhand smoke exposure in childhood increases lung cancer risk later in life
8. Exposure to secondhand cigarette smoke over a lifetime increased breast cancer risk later in life
9. A second skin
10. Study in Spain and Romania confirms radon as second leading cause of lung cancer
11. Second-hand smoking results in liver disease, study finds
Post Your Comments:
(Date:11/4/2015)... New York , November 4, 2015 ... to a new market report published by Transparency Market ... Share, Growth, Trends and Forecast 2015 - 2022", the global ... of US$ 30.3 bn by 2022. The market is ... the forecast period from 2015 to 2022. Rising security ...
(Date:10/29/2015)... 29, 2015 Daon, a global leader in ... released a new version of its IdentityX Platform ... North America have already installed IdentityX v4.0 ... a FIDO UAF certified server component as ... activate FIDO features. These customers include some of the ...
(Date:10/29/2015)... Today, LifeBEAM , a leader ... a global leader in technical performance sports clothing ... advanced bio-sensing technology. The hat will allow fitness ... biometrics to improve overall training performance. As a ... bring together the most advanced technology, extensive understanding ...
Breaking Biology News(10 mins):
(Date:11/30/2015)... Nov. 30, 2015 Spherix Incorporated (Nasdaq: ... to the fostering and monetization of intellectual property, ... prospective initiatives designed to create shareholder value. ... of Spherix. "Based on published reports, the total ... $50 billion and Spherix will seek to secure ...
(Date:11/30/2015)... SAN DIEGO , Nov. 30, 2015 ... today that the company has acquired Cypher Genomics, Inc., ... and robust human genomic interpretation software solutions. The ... who will join HLI including Cypher CEO and Co-founder, ... head of HLI,s Pediatric Business.  Financial details of the ...
(Date:11/30/2015)... , Nov. 30, 2015  Aytu BioScience, Inc. (OTCQB: ... and related conditions, will present at two upcoming investor ... an interactive real-time virtual conference, to be held December ... Conference, to be held December 2 nd & ... and streamed live via webcast. ...
(Date:11/30/2015)... , Nov. 30, 2015  Northwest Biotherapeutics (NASDAQ: ... DCVax® personalized immune therapies for solid tumor cancers, announced ... additional independent director, and the Company welcomes Neil ... in a recent anonymous internet report on NW Bio.  ... Linda Powers stated, "We agree with ...
Breaking Biology Technology: